It's almost impossible to turn on the tube these days without seeing an ad from a drug company. The typical scenario goes something like this: Person with a disease or problem is all smiles, thanks to the benefits of the advertised drug. But there's a catch.
Major LTC insurer posts $844 million loss, shares tumble ... Kindred's quarterly numbers suggest restructuring is paying off ... Monkey study raises hopes of weekly injections to fend off Alzheimer's ... Dementia can be predicted by walking speed and memory complaints, research suggests
The number of people with long-term care needs is set to triple by 2050, and dementia care will be increasingly at the forefront for providers, according to a new report from Alzheimer's Disease International.
A friend who has spent a lifetime studying Alzheimer's disease once offered this double-edged advice: If you can make it all the way to age 90, there's a good chance you'll avoid the disease.
A Georgetown University neurologist "was shocked" to find 48% of his study enrollees showed signs of undiagnosed prediabetes and diabetes.
Advances in genetics and pharmaceuticals could lead to a cure for dementia by 2020, according to United Kingdom Secretary of Health Jeremy Hunt.
Certain common medications can trigger or slow Alzheimer's disease, according to researchers.
Certain widely prescribed medications can trigger or slow the progress of Alzheimer's disease, according to recently published research.
Cognitive impairment can result when older adults are taking or given medications with strong anticholinergic effects, a new study has found.
There has been a trend of late to refer to specialized care of individuals with dementia as "memory care." I understand the need for a quick, catchy title for a new product or service line in long-term care, but I worry about the message this one may send and the mindset it might create in management, families and employees. Here's why.
The housing and care of Alzheimer's disease and dementia patients has been on a roll. The recent progression of designs and elements has led to improvements for residents and the staff who care for them.
A major breakthrough in Alzheimer's research could lead to new and more effective ways of treating the disease, according to a recently released study in the Journal of Neuroscience.
The Food and Drug Administration issued draft guidance Thursday on clinical trials for early-stage Alzheimer's drugs.
Researchers say they've made a major breakthrough in the effort to develop an Alzheimer's disease vaccine.
A new study has determined people with Alzheimer's disease are less likely to participate in clinical trials without a spouse caregiver.
Insulin nasal spray could delay the decline of cognitive function in those with Alzheimer's and mild cognitive impairment, according to a new study.
Using iPods to reconnect long-term care residents with their favorite music is a simple intervention with great upside potential and no side effects. They're an inexpensive tool that can have a positive impact on resident quality of life, which, in turn, should be reflected in an important subset of MDS 3.0 scores.
Kidney dialysis treatments near the end of life might do more harm than good and aggressive care for individuals with advanced dementia may be well-intentioned but misdirected efforts, results from a pair of new studies suggest.